Effect of COVID-19 with or without acute kidney injury on inpatient mortality in England: a national observational study using administrative data

Objectives To evaluate hospital outcomes and their predictors during the pandemic for patients with and without COVID-19, stratified by the presence of acute kidney injury (AKI).Design Retrospective observation study using the Hospital Episodes Statistics database for England.Participants 2 385 337...

Full description

Saved in:
Bibliographic Details
Main Authors: Nitin V Kolhe, Maarten Taal, Richard Fluck
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/3/e095020.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850206974161977344
author Nitin V Kolhe
Maarten Taal
Richard Fluck
author_facet Nitin V Kolhe
Maarten Taal
Richard Fluck
author_sort Nitin V Kolhe
collection DOAJ
description Objectives To evaluate hospital outcomes and their predictors during the pandemic for patients with and without COVID-19, stratified by the presence of acute kidney injury (AKI).Design Retrospective observation study using the Hospital Episodes Statistics database for England.Participants 2 385 337 unique hospital admissions of adult patients from March 2020 to March 2021 in England.Main outcome measures COVID-19 cases were identified by the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code of U07.1. Patients with suspected COVID-19 (U07.2 code) and patients with end-stage kidney disease on chronic dialysis (N18.6 and Z99.2) were excluded. AKI cases were identified by the ICD10 code. Patients were categorised into four groups based on COVID-19 and AKI diagnoses: Group 1—neither; Group 2—COVID-19 only; Group 3—AKI only; Group 4—both. A multivariable logistic regression model was created with in-hospital mortality as the outcome, including diagnostic groups, demographics, admission methods, comorbidity severity, deprivation index and intensive therapy unit (ITU) admission.Results Among 2 385 337 admissions involving 663 628 patients, 856 544 had AKI (N17 codes) and 1 528 793 did not. Among patients without AKI, there were 1,008,774 admissions among 133,988 individuals without COVID-19 (Group 1) and 520,019 admissions among 256,037 individuals with COVID-19 (Group 2). Among patients with AKI, there were 630,342 admissions among 218,270 individuals without COVID-19 (Group 3) and 226,202 admissions among 55,333 individuals with COVID-19 (Group 4). Patients in group 4 were older (75.4 ± 13.8 years) and had greater length of stay (17.1 ± 17 days) than all other groups. They also had and had a greater proportion of males, ethnic minorities and comorbidities than other groups. Mortality was highest in Group 4 (28.7%) and lowest in Group 1 (1.1%). The increased risk of death persisted after controlling for multiple baseline factors (OR for death vs Group 1: Group 4—22.28, Group 2—9.67, Group 3—6.44). ITU admission was least required in Group 1 (1.2%) and most in Group 4 (10.9%), with mortality at 4.8% versus 47.8%, respectively.Conclusions Patients with COVID-19 and AKI have a high risk of mortality and should be recognised early and provided with optimal support. Planning for future pandemics should ensure adequate critical care and acute dialysis capacity.Trial registration number NCT04579562.
format Article
id doaj-art-ecf53a796e964022ab4af79d1fa22b02
institution OA Journals
issn 2044-6055
language English
publishDate 2025-03-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-ecf53a796e964022ab4af79d1fa22b022025-08-20T02:10:39ZengBMJ Publishing GroupBMJ Open2044-60552025-03-0115310.1136/bmjopen-2024-095020Effect of COVID-19 with or without acute kidney injury on inpatient mortality in England: a national observational study using administrative dataNitin V Kolhe0Maarten Taal1Richard Fluck22Department of Renal Medicine, Royal Derby Hospital, Derby, UKDepartment of Renal Medicine, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UKDepartment of Renal Medicine, Royal Derby Hospital, Derby, UKObjectives To evaluate hospital outcomes and their predictors during the pandemic for patients with and without COVID-19, stratified by the presence of acute kidney injury (AKI).Design Retrospective observation study using the Hospital Episodes Statistics database for England.Participants 2 385 337 unique hospital admissions of adult patients from March 2020 to March 2021 in England.Main outcome measures COVID-19 cases were identified by the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code of U07.1. Patients with suspected COVID-19 (U07.2 code) and patients with end-stage kidney disease on chronic dialysis (N18.6 and Z99.2) were excluded. AKI cases were identified by the ICD10 code. Patients were categorised into four groups based on COVID-19 and AKI diagnoses: Group 1—neither; Group 2—COVID-19 only; Group 3—AKI only; Group 4—both. A multivariable logistic regression model was created with in-hospital mortality as the outcome, including diagnostic groups, demographics, admission methods, comorbidity severity, deprivation index and intensive therapy unit (ITU) admission.Results Among 2 385 337 admissions involving 663 628 patients, 856 544 had AKI (N17 codes) and 1 528 793 did not. Among patients without AKI, there were 1,008,774 admissions among 133,988 individuals without COVID-19 (Group 1) and 520,019 admissions among 256,037 individuals with COVID-19 (Group 2). Among patients with AKI, there were 630,342 admissions among 218,270 individuals without COVID-19 (Group 3) and 226,202 admissions among 55,333 individuals with COVID-19 (Group 4). Patients in group 4 were older (75.4 ± 13.8 years) and had greater length of stay (17.1 ± 17 days) than all other groups. They also had and had a greater proportion of males, ethnic minorities and comorbidities than other groups. Mortality was highest in Group 4 (28.7%) and lowest in Group 1 (1.1%). The increased risk of death persisted after controlling for multiple baseline factors (OR for death vs Group 1: Group 4—22.28, Group 2—9.67, Group 3—6.44). ITU admission was least required in Group 1 (1.2%) and most in Group 4 (10.9%), with mortality at 4.8% versus 47.8%, respectively.Conclusions Patients with COVID-19 and AKI have a high risk of mortality and should be recognised early and provided with optimal support. Planning for future pandemics should ensure adequate critical care and acute dialysis capacity.Trial registration number NCT04579562.https://bmjopen.bmj.com/content/15/3/e095020.full
spellingShingle Nitin V Kolhe
Maarten Taal
Richard Fluck
Effect of COVID-19 with or without acute kidney injury on inpatient mortality in England: a national observational study using administrative data
BMJ Open
title Effect of COVID-19 with or without acute kidney injury on inpatient mortality in England: a national observational study using administrative data
title_full Effect of COVID-19 with or without acute kidney injury on inpatient mortality in England: a national observational study using administrative data
title_fullStr Effect of COVID-19 with or without acute kidney injury on inpatient mortality in England: a national observational study using administrative data
title_full_unstemmed Effect of COVID-19 with or without acute kidney injury on inpatient mortality in England: a national observational study using administrative data
title_short Effect of COVID-19 with or without acute kidney injury on inpatient mortality in England: a national observational study using administrative data
title_sort effect of covid 19 with or without acute kidney injury on inpatient mortality in england a national observational study using administrative data
url https://bmjopen.bmj.com/content/15/3/e095020.full
work_keys_str_mv AT nitinvkolhe effectofcovid19withorwithoutacutekidneyinjuryoninpatientmortalityinenglandanationalobservationalstudyusingadministrativedata
AT maartentaal effectofcovid19withorwithoutacutekidneyinjuryoninpatientmortalityinenglandanationalobservationalstudyusingadministrativedata
AT richardfluck effectofcovid19withorwithoutacutekidneyinjuryoninpatientmortalityinenglandanationalobservationalstudyusingadministrativedata